Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting
Clinical trial NCT02203253 · COMPLETED
Trial details
- NCT number
- NCT02203253
- Sponsor
- China Medical University, China
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2016-07-01
- Enrollment
- 642
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.